ID: MRFR/MED/3980-HCR | February 2021 | Region: Global | 120 Pages
TABLE OF CONTENT
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Surgery Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterβs Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 7. Global Ischemic Stroke Market, By Diagnosis
7.1 Introduction
7.2 Computed Tomography (CT)
7.3.1 Market Estimates & Forecast, 2020 β 2027
7.3 Magnetic Resonance Imaging (MRI)
7.3.1 Market Estimates & Forecast, 2020 β 2027
7.4 Carotid Ultrasound
7.4.1 Market Estimates & Forecast, 2020 β 2027
7.5 Cerebral Angiography
7.5.1 Market Estimates & Forecast, 2020 β 2027
7.6 Electrocardiography
7.7.1 Market Estimates & Forecast, 2020 β 2027
7.8 Echocardiography
7.8.1 Market Estimates & Forecast, 2020 β 2027
7.4 Others
Chapter 8. Global Ischemic Stroke Market, By Drug Class
8.1 Introduction
8.2 Tissue Plasminogen Activator
8.2.1 Market Estimates & Forecast, 2020 β 2027
8.3 Anticoagulant
8.3.1 Market Estimates & Forecast, 2020 β 2027
8.4 Antiplatelet
8.4.1 Market Estimates & Forecast, 2020 β 2027
8.5 Antihypertensive
8.5.1 Market Estimates & Forecast, 2020 β 2027
8.6 Others
Chapter 9. Global Ischemic Stroke Market, By Surgery
9.1 Introduction
9.2 Carotid Endarterectomy
9.2.1 Market Estimates & Forecast, 2020 β 2027
9.3 Angioplasty
9.3.1 Market Estimates & Forecast, 2020 β 2027
9.4 Endovascular Mechanical Thrombectomy
9.4.1 Market Estimates & Forecast, 2020 β 2027
Chapter 10. Global Ischemic Stroke Market, By End User
10.1 Introduction
10.2 Hospitals & Clinics
10.2.1 Market Estimates & Forecast, 2020 β 2027
10.3 Medical Institutes
10.3.1 Market Estimates & Forecast, 2020 β 2027
10.4 Research Organization
10.4.1 Market Estimates & Forecast, 2020 β 2027
10.5 Others
10.5.1 Market Estimates & Forecast, 2020 β 2027
Chapter. 11 Global Ischemic Stroke Market, By Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 U.S.
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 Italy
11.3.1.4 Spain
11.3.1.5 U.K
11.3.1.6 Rest Of Western Europe
11.3.2 Eastern Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Republic Of Korea
11.4.6 Rest Of Asia Pacific
11.5 The Middle East & Africa
11.5.1 United Arab Emirates
11.5.2 Saudi Arabia
11.5.3 Rest Of The Middle East & Africa
Chapter 12 Company Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Key Development & Strategies
12.3.1 Key Developments
Chapter 13 Company Profiles
13.1 Abbott Laboratories
13.1.1 Company Overview
13.1.2 Drug Class Overview
13.1.3 Financials
13.1.4 SWOT Analysis
13.2 Medtronic Plc
13.2.1 Company Overview
13.2.2 Drug Class Overview
13.2.3 Financial Overview
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Boston Scientific Corporation
13.3.1 Company Overview
13.3.2 Drug Class Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4 Cordis Corporation
13.4.1 Company Overview
13.4.2 Drug Class/Business Segment Overview
13.4.3 Financial Overview
13.4.4 Key Development
13.4.5 SWOT Analysis
13.5 Merck & Co., Inc.
13.5.1 Company Overview
13.5.2 Drug Class Overview
13.5.3 Financial Overview
13.5.4 Key Developments
13.6 Koninklijke Philips N.V.
13.6.1 Company Overview
13.6.2 Drug Class Overview
13.6.3 Financial Overview
13.6.4 Key Developments
13.7 GE Healthcare
13.7.1 Overview
13.7.2 Drug Class Overview
13.7.3 Financials
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.8 Stryker Corporation
13.8.1 Company Overview
13.8.2 Drug Class/Business Segment Overview
13.8.3 Financial Overview
13.8.4 Key Development
13.8.5 SWOT Analysis
13.9 Pfizer Inc.
13.9.1 Company Overview
13.9.2 Drug Class Overview
13.9.3 Financial Overview
13.9.4 Key Developments
13.10 Others
Chapter 14 MRFR Conclusion
14.1 Key Findings
14.1.1 From CEOβs View Point
14.1.2 Unmet Needs Of The Market
14.2 Key Companies To Watch
14.3 Prediction Of Pharmaceutical Industry
Chapter 15 Appendix
LIST OF TABLES
Table 1 Ischemic Stroke Industry Synopsis, 2020 β 2027
Table 2 Ischemic Stroke Market Estimates And Forecast, 2020 β 2027, (USD Million)
Table 3 Ischemic Stroke Market By Region, 2020 β 2027, (USD Million)
Table 4 Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 5 Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 6 Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 7 Ischemic Stroke Market By End Users, 2020 β 2027, (USD Million)
Table 8 North America Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 9 North America Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 10 North America Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 11 North America Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 12 US Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 13 US Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 14 US Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 15 US Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 16 Canada Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 17 Canada Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 18 Canada Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 19 Canada Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 20 South America Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 21 South America Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 22 South America Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 23 South America Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 24 Europe Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 25 Europe Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 26 Europe Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 27 Europe Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 28 Western Europe Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 29 Western Europe Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 30 Western Europe Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 31 Western Europe Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 32 Eastern Europe Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 33 Eastern Europe Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 34 Eastern Europe Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 35 Eastern Europe Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 36 Asia Pacific Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 37 Asia Pacific Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 38 Asia Pacific Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 39 Asia Pacific Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
Table 40 The Middle East & Africa Ischemic Stroke Market By Diagnosis, 2020 β 2027, (USD Million)
Table 41 The Middle East & Africa Ischemic Stroke Market By Drug Class, 2020 β 2027, (USD Million)
Table 42 The Middle East & Africa Ischemic Stroke Market By Surgery, 2020 β 2027, (USD Million)
Table 43 The Middle East & Africa Ischemic Stroke Market By End User, 2020 β 2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation For Ischemic Stroke Market
Figure 3 Segmentation Market Dynamics For Ischemic Stroke Market
Figure 4 Global Ischemic Stroke Market Share, By Diagnosis 2020
Figure 6 Global Ischemic Stroke Market Share, By Drug Class 2020
Figure 7 Global Ischemic Stroke Market Share, By Surgery, 2020
Figure 8 Global Ischemic Stroke Market Share, By End Users, 2020
Figure 9 Global Ischemic Stroke Market Share, By Region, 2020
Figure 10 North America Ischemic Stroke Market Share, By Country, 2020
Figure 11 Europe Ischemic Stroke Market Share, By Country, 2020
Figure 12 Asia Pacific Ischemic Stroke Market Share, By Country, 2020
Figure 13 The Middle East & Africa Ischemic Stroke Market Share, By Country, 2020
Figure 14 Global Ischemic Stroke Market: Company Share Analysis, 2020 (%)
Figure 15 Abbott Laboratories: Key Financials
Figure 16 Abbott Laboratories: Segmental Revenue
Figure 17 Abbott Laboratories: Geographical Revenue
Figure 18 Medtronic Plc: Key Financials
Figure 19 Medtronic Plc: Segmental Revenue
Figure 20 Medtronic Plc: Geographical Revenue
Figure 21 Boston Scientific Corporation: Key Financials
Figure 22 Boston Scientific Corporation: Segmental Revenue
Figure 23 Boston Scientific Corporation: Geographical Revenue
Figure 24 Cordis Corporation: Key Financials
Figure 25 Cordis Corporation: Segmental Revenue
Figure 26 Cordis Corporation: Geographical Revenue
Figure 27 Merck & Co., Inc.: Key Financials
Figure 28 Merck & Co., Inc.: Segmental Revenue
Figure 29 Merck & Co., Inc.: Geographical Revenue
Figure 30 Koninklijke Philips N.V.: Key Financials
Figure 31 Koninklijke Philips N.V.: Segmental Revenue
Figure 32 Koninklijke Philips N.V.: Geographical Revenue
Figure 33 GE Healthcare: Key Financials
Figure 34 GE Healthcare: Segmental Revenue
Figure 35 GE Healthcare: Geographical Revenue
Figure 36 Stryker Corporation: Key Financials
Figure 37 Stryker Corporation: Segmental Revenue
Figure 38 Stryker Corporation: Geographical Revenue
Figure 39 Pfizer Inc.: Key Financials
Figure 40 Pfizer Inc.: Segmental Revenue
Figure 41 Pfizer Inc.: Geographical Revenue
Bottom of Form
$31,702.20 million
7.8%
North America
2020β2030
Ischemic Stroke Market Overview:
According to the industry's latest report, the worldwide Ischemic Stroke market has been expected to grow at a CAGR of 7.8% over the estimated forecast period of 2021-2030.
Strokes generally happen while the blood vessel in the brain breaks and bleeding comes out, or it may happen while there is some block in the blood supply to the brain. Due to this fracture or any kind of blockage, the blood and the oxygen couldn't reach inside the brain tissues. There are normally three types of strokes that are a common disease for every individual worldwide, such as a transient ischemic attack, hemorrhagic stroke, and ischemic stroke. Common diagnosis procedures are included in this method, such as blood tests, magnetic resonance imaging, ultrasound, computerized tomography scan, cerebral angiogram and echocardiograms. All the treatments for this disease are included in aspirin, other antiplatelets and anticoagulants.
The raising of health awareness, rise in the incidence of diabetes, the surge in the number of tobacco users and the growth in the geriatric population helps to drive the ischemic stroke market. However, the new emerging technologies for the diagnosis & treatment procedures for ischemic stroke also help to contribute to the ischemic stroke market growth. The ischemic stroke normally occurs due to the sudden cessation of the maximum amount of blood reaching sections in the brain. The ischemic strokes can be divided into territory affected and mechanism. All the clots inside the body are either thrombotic or embolic, which depends on the development within the body parts. A thrombotic stroke is a common of two, which happens while a clot formation occurs within an artery of the brain. Embolic stroke also occurs while the clot or some kind of small piece of plaque that is fatty deposit breaks from anywhere in the body like in the heart and travels through the bloodstream system that only becomes stuck like a narrow vessel inside the brain. All the symptoms completely depend on the severity of the stroke and the specific location in the brain. Some individuals didn't experience any symptoms. All the symptoms of ischemic stroke include paralysis of one side of the body, changes in alertness, not getting the perfect experience of smells, hearing and taste, swallowing problems, loss of balance of the body, and sometimes it might affect the eye-sight.
COVID-19 Analysis:
According to the Ischemic Stroke market analysis, this disease is caused by the virus, which is called the severity of acute respiratory syndrome of coronavirus 2, which is transmitted within human beings. In addition, due to the outbreak of COVID-19, there is some reduction of hospital sectors. It was due to the fact that people are getting feared about the infection during the period of distancing and the lockdown situation. Several governments implemented a strict lockdown in their region for health emergencies. The international commercial activities and trade sectors have been stopped for a few periods. During the lockdown, the demands for advanced medical devices have been increased so far.
The impact of the COVID-19 has directly affected the global hospital and medical sectors. The overall impact of the disease on the ischemic stroke market value was recorded to be very fairly negative. Due to the decrease in production and manufacturing work, investors have faced a huge loss. Furthermore, the prominent players in this industry have bound to reduce the investment in raw materials and resources due to several hospital-based treatments for ischemic stroke patients. Furthermore, it is one of the most important factors to overcome from this challenging period. Because this global pandemic has been strongly affected by every global industry, most manufacturers want to meet the demands of several sectors.
The Chief Factors Existing in the Market:
Due to the raising of global health awareness just after the lockdown from the epidemic, most of the Ischemic Stroke market key drivers want to fix and set their production work to overcome the challenge of global demands.
The major challenge for every company is how to meet and overcome the situation from the global pandemic. Most of the investors have been facing a huge loss during this pandemic. Due to the lockdown, the entire ischemic stroke market size has been crashed, and every manufacturer wants to take off their business sectors.
After the lockdown, the global market has been introduced lots of new market players who contributed to developing and producing a large number of productions. Most of the key factor is that the competition between the markets has been raised significantly due to this.
During the lockdown, the ischemic stroke market cost has been significantly growing, for which most of the manufacturing products and the cost of the raw materials have significantly improved. To overcome such restraints, most key market players are performing to modernize their factories and production work.
Cumulative Evaluation of the Market:
Raising awareness of global health is essential, especially after decreasing infection of the global pandemic. Many people have become so aware of health consciousness. But still, some kinds of other diseases that can easily affect the body. But the growth of the hospital and modern medical devices have raised this ischemic stroke market tremendously. Due to this, investors also give the chances to the new generation and the new market players who want to set their business in the market. According to this, the new Ischemic Stroke market players can perform a huge number of productions, especially to meet the present global demand. Just after the lockdown, the international commercial business also went on, and due to the trade partnerships and raising of several industrial facilities, most of the advanced medical equipment and medicine cures are coming out in this global market which will be helpful for the patient.
Market Segmentation:
The Ischemic Stroke market has been segmented into five sections: diagnosis, drug class, surgery, end-users, and geographical. The market has been classified into seven platforms in terms of the diagnosis section: computed tomography, magnetic resonance imaging, carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others. The basis of drug class is further classified into five sections: tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others. The surgery section is further segmented into three parts: carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy. In terms of the end-user section, the Ischemic Stroke market is classified into four segments: hospitals & clinics, medical institutes, research organizations, and others. According to the basis of the regional or geographical section, the global market has been classified into five different regions such as Asia-Pacific, Europe, North America, South America and Middle East & Africa.
Regional Analysis:
Due to the favorable government initiatives, technological innovations and the rising demand for ischemic stroke products, North America has been expected to hold the Ischemic Stroke market during the upcoming years. Moreover, most of the prominent market players are now willing to focus on the increase of production work. Due to this, the global market has been expected to increase so far in the upcoming future. In this modern world, several numbers of emerging technology and modern medical equipment have come up around this world for which the procedures of medical workers have been so easy now. Due to the advanced technology and research facilities, there are a lot of chances that generate to invent new cures and medicines.
Due to this, most European regions are willing to establish a maximum number of medical facilities that can easily drive the growth of global market sectors. Furthermore, most of the investors want to invest their funds in the manufacturing industries to grow the production work.
Competitive Intensity within the Industry:
The leading market players of the Ischemic Stroke market have always been looking for an increasing manufacturing rate for global customers. Due to this, the level of competition has been found in the market. The incoming of new faces in this business sector has given an opportunity for several companies to stand out in this market sector. As the global stocks have improved, the share values have also grown significantly. According to this, the investors also want to give a chance to some of the market's new players as well as the prominent market drivers.
Some of the list of key market players:
Recent Market Development:
Some of the major Asian regions want to give full efforts to improve their production work and meet the global challenge. Such economic regions also hold a huge number of potential to increase their manufacturing plants and factory production as one of the Ischemic Stroke market emerging player CERENOVUS has launched EMBOGUARD, which is a next generation balloon guide catheter that can be used in the endovascular procedures and such patients who are suffering from ischemic stroke problems.
Report Overview:
All the information about the ischemic stroke market and its symptoms to proper treatment are in this detailed report. Information about the key challenging fact that occurs during the global pandemic, and the companies that are mostly affected by the lockdown procedures are also available. The report offers complete details on the classification of global ischemic market sectors in the market segment section. All the reports provide complete and thorough info about the market's more prominent players and the investors.
Key Industrial Segment:
Diagnosis:
Drug Class:
Surgery:
End-User:
Regional Analysis:
Report Attribute/Metric | Details |
---|---|
Market Size | 2030: Significant Value |
CAGR | 8.50% (2020-2030) |
Base Year | 2019 |
Forecast Period | 2020-2030 |
Historical Data | 2018 |
Forecast Units | Value (USD Million) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Diagnosis, Drug Class, Surgery and End-Users |
Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
Key Vendors | Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others |
Key Market Opportunities | New product launches and R&D Amongst major key Players |
Key Market Drivers |
|
Frequently Asked Questions (FAQ) :
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
Ischemic stroke market is expected to grow at a CAGR of approximately 8.50% during the forecast period 2020-2030.
Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market.
The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products.
Some of key the players in the ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.), Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.), GE Healthcare (U.S.), Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others